Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia

References

• Mortensen JE, Fisher MC, LiPuma JJ. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol 1995;16:30–2.
   Google Scholar
• Huang CH, Jang TN, Liu CY, Fung CP, Yu KW, Wong WW. Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infect 2001;34:215–9.
   PubMedGoogle Scholar
• Siddiqui AH, Mulligan ME, Mahenthiralingam E, Hebden J, Brewrink J, Qaiyumi S, . An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Infect Control Hosp Epidemiol 2001;22:419–22.
   Google Scholar
• Estivariz CF, Bhatti LI, Pati R, Jensen B, Arduino MJ, Jernigan D, . An outbreak of Burkholderia cepacia associated with contamination of albuterol and nasal spray. Chest 2006;130:1346–53.
   PubMed Web of Science ®Google Scholar
• Nasser RM, Rahi AC, Haddad MF, Daoud Z, Irani-Hakime N, Almawi WY. Outbreak of Burkholderia cepacia bacteremia traced to contaminated hospital water used for dilution of an alcohol skin antiseptic. Infect Control Hosp Epidemiol 2004;25:231–9.
   PubMed Web of Science ®Google Scholar
• Mann T, Ben-David D, Zlotkin A, Shachar D, Keller N, Toren A, . An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients. Infection 2010;38:187–94.
   Web of Science ®Google Scholar
• Jarvis WR, Olson D, Tablan O, Martone WJ. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol 1987;3:233–6.
   PubMedGoogle Scholar
• Maningo E, Watanakunakorn C. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect 1995;31:89–92.
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility testing. 16^th Informational supplement. M100-S17. Wayne, PA: CLSI; 2007.
   Google Scholar
• Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med 1992;20:724–6.
   PubMed Web of Science ®Google Scholar
• Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–40.
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, . Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1–45.
   PubMed Web of Science ®Google Scholar
• Saginur R, Suh KN. Staphylococcus aureus bacteraemia of unknown primary source: where do we stand? Int J Antimicrob Agents 2008;32(Suppl 1):S21–5.
   Google Scholar
• Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–55.
   PubMed Web of Science ®Google Scholar
• World Health Organization. International statistical classification of diseases and related health problems 10^th revision. 2nd. Geneva: World Health Organization; 2004.
   Google Scholar
• Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003;115: 529–35.
   PubMed Web of Science ®Google Scholar
• Frangolias DD, Mahenthiralingam E, Rae S, Raboud JM, Davidson AG, Wittmann R, . Burkholderia cepacia in cystic fibrosis. Variable disease course. Am J Respir Crit Care Med 1999;160:1572–7.
   Google Scholar
• Hoiby N. Haemophilus influenzae, Staphylococcus aureus, Pseudomonas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis. Chest 1988;94: 97S–103S.
   Google Scholar
• Holmes A, Nolan R, Taylor R, Finley R, Riley M, Jiang RZ, . An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 1999;179:1197–205.
   PubMedGoogle Scholar
• Goldmann DA, Klinger JD. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr 1986; 108:806–12.
   Google Scholar
• Dizbay M, Tunccan OG, Sezer BE, Aktas F, Arman D. Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance. J Infect Dev Ctries 2009;3:273–7.
   Web of Science ®Google Scholar
• Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, . Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 1998;26: 1793–800.
   PubMed Web of Science ®Google Scholar
• Anami EH, Grion CM, Cardoso LT, Kauss IA, Thomazini MC, Zampa HB, . Serial evaluation of SOFA score in a Brazilian teaching hospital. Intensive Crit Care Nurs 2010;26:75–82.
   Google Scholar
• Routsi C, Pratikaki M, Sotiropoulou C, Platsouka E, Markaki V, Paniara O, . Application of the sequential organ failure assessment (SOFA) score to bacteremic ICU patients. Infection 2007;35:240–4.
   Google Scholar
• Cheong HS, Kang CI, Wi YM, Ko KS, Chung DR, Lee NY, . Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia. Eur J Clin Microbiol Infect Dis 2008;27:1219–25.
   PubMed Web of Science ®Google Scholar
• Lodise TP Jr, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, . Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother 2007;51:3510–5.
   PubMed Web of Science ®Google Scholar
• Erbay A, Idil A, Gozel MG, Mumcuoglu I, Balaban N. Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections. Int J Antimicrob Agents 2009;34:575–9.
   PubMed Web of Science ®Google Scholar
• Deris ZZ, Harun A, Shafei MN, Rahman RA, Johari MR. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia. Southeast Asian J Trop Med Public Health 2009;40:140–7.
   Google Scholar